Gurugram's Fortis Memorial Research Institute begins Sputnik vaccine trial run for public
India | June 27, 2021 22:31 ISTGurugram's Fortis Memorial Research Institute has begun trial run of Russian COVID-19 vaccine Sputnik V for the general public.
Gurugram's Fortis Memorial Research Institute has begun trial run of Russian COVID-19 vaccine Sputnik V for the general public.
Indraprastha Apollo had earlier said that it would tentatively start administering the two-dose vaccine by June 25. A Max Group Hospitals spokesperson said: "Sputnik V Covid vaccine is not available as of today."
The roll-out of Russian COVID-19 vaccine 'Sputnik V' at various private hospitals in the Delhi-NCR region has been delayed again
A spokesperson of Apollo Hospitals said the facility in Delhi will tentatively start administering 2-dose vaccine by June 25.
Sputnik V will soon offer a booster shot, adjusted to work against the Delta variant of coronavirus to other vaccine manufacturers, the Russian vaccine maker announced on Thursday.
The limited pilot soft launch of the Sputnik V vaccine in India has now been successfully scaled up to other cities including Delhi, Bengaluru, Mumbai, Chennai and Kolkata.
The Sputnik V vaccine was accorded emergency use authorization by the Drugs Controller General of India
Apart from the Apollo hospital, another private hospital Madhukar Rainbow Children's Hospital will start administering the Sputnik V by the end of this week
Russia's COVID-19 vaccine - Sputnik V - is expected to be available at Indraprastha Apollo hospital in Delhi from June 15, sources told news agency ANI. The program for Sputnik V rollout at the hospital will depend on the consignment received, sources said.
The Uttar Pradesh government will organise special vaccination booths for street vendors, auto-rickshaw drivers, e-rickshaw and rickshaw drivers in a bid to encourage them to take the jabs.
The Haryana government on Saturday informed that an international pharma company has given an expression of interest to provide upto 60 million doses of Russia's Sputnik V vaccine at a cost of Rs 1,120 per dose.
Pune-based SII has collaborated with Gamaleya Research Institute of Epidemiology and Microbiology, Moscow in Russia for developing Sputnik V at its licensed Hadapsar facility.
The Serum Institute has applied to the DGCI seeking permission to manufacture Sputnik V.
According to the data from over 186,000 people aged 60-79, more than 40,000 of whom received a shot of Sputnik Light (first dose of Sputnik V) as part of the mass-scale civil vaccination program, the infection rate between 21st and 40th day from the date of receiving the first dose was only 0.446 per cent.
Dr Reddy's Laboratories is in a pact with Russian Direct Investment Fund to sell the first 125 million people doses (250 million vials) of SputnikV in India.
Sputnik Light is the first component (recombinant human adenovirus serotype number 26 (rAd26)) of Sputnik V – the world’s first registered vaccine against coronavirus.
Arvind Kejriwal said Delhi is likely to get a portion of the Sputnik V consignment that will be imported by the firm concerned after June 20.
BJP leaders "criticise and abuse" Arvind Kejriwal whenever he works for the people, Delhi Deputy Chief Minister Manish Sisodia alleged on Monday.
The Centre on Monday told Supreme Court that entire eligible population will be vaccinated against Covid-19 by 2021-end.
India has become the 60th country to authorise the use of the Russian Sputnik V COVID-19 vaccine against coronavirus.
Top News
Latest News
